Anti TAG-72 humanized antibody (Aprogen)

N/A

Report date: 2022/02/14 17:42:59

Base Information

Drug NameAnti TAG-72 humanized antibody (Aprogen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionTumor-associated glycoprotein 72 inhibitors

TargetsTumor-associated glycoprotein 72

Therapy Area/IndicationsAdenocarcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAprogen

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAprogen

Active IndicationsN/A

Inactive IndicationsAdenocarcinoma

ATC CodeN/A